Schroder Investment Management Group’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-84,800	Closed	-$6.46M	–	1358
2019 Q3	$6.46M	Buy	84,800 +18,500	+28%	+$1.5M	0.01%	709
2019 Q2	$5.66M	Buy	66,300 +12,600	+23%	+$1.25M	0.01%	674
2019 Q1	$5.8M	Buy	+53,700	New	+$5.35M	0.01%	676
2018 Q3	–	Sell	-24,416	Closed	-$2.81M	–	1348
2018 Q2	$2.81M	Sell	24,416 -233,504	-91%	-$25.7M	﹤0.01%	793
2018 Q1	$25.5M	Sell	257,920 -168,535	-40%	-$17.1M	0.04%	404
2017 Q4	$44.7M	Sell	426,455 -135,983	-24%	-$14.9M	0.07%	312
2017 Q3	$62.9M	Sell	562,438 -118,804	-17%	-$12.9M	0.11%	235
2017 Q2	$76.6M	Sell	681,242 -43,260	-6%	-$4.89M	0.14%	187
2017 Q1	$87.2M	Sell	724,502 -105,139	-13%	-$11.6M	0.16%	177
2016 Q4	$87.3M	Sell	829,641 -38,578	-4%	-$4.04M	0.17%	156
2016 Q3	$95.9M	Buy	868,219 +32,100	+4%	+$4.25M	0.18%	134
2016 Q2	$122M	Buy	836,119 +142,051	+20%	+$20.1M	0.24%	99
2016 Q1	$98.5M	Buy	694,068 +295,727	+74%	+$42M	0.2%	121
2015 Q4	$61.6M	Buy	398,341 +95,637	+32%	+$14M	0.13%	193
2015 Q3	$43.3M	Buy	302,704 +289,604	+2,211%	+$40.5M	0.09%	275
2015 Q2	$1.86M	Buy	+13,100	New	+$1.87M	﹤0.01%	840
2014 Q4	–	Sell	-286,038	Closed	-$44M	–	1501
2014 Q3	$44M	Sell	286,038 -24,762	-8%	-$3.73M	0.06%	306
2014 Q2	$43.6M	Buy	+310,800	New	+$34.5M	0.05%	305